Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100


Mapping mouse IL-13 binding regions using structure modeling, molecular docking, and high-density peptide microarray analysis.

Madala SK, Dolan MA, Sharma D, Ramalingam TR, Wilson MS, Mentink-Kane MM, Masison DC, Wynn TA.

Proteins. 2011 Jan;79(1):282-93. doi: 10.1002/prot.22881.


Molecular basis for shared cytokine recognition revealed in the structure of an unusually high affinity complex between IL-13 and IL-13Ralpha2.

Lupardus PJ, Birnbaum ME, Garcia KC.

Structure. 2010 Mar 10;18(3):332-42. doi: 10.1016/j.str.2010.01.003.


Characterization of the interaction between interleukin-13 and interleukin-13 receptors.

Arima K, Sato K, Tanaka G, Kanaji S, Terada T, Honjo E, Kuroki R, Matsuo Y, Izuhara K.

J Biol Chem. 2005 Jul 1;280(26):24915-22.


The association of the cytoplasmic domains of interleukin 4 receptor alpha and interleukin 13 receptor alpha 2 regulates interleukin 4 signaling.

Andrews AL, Nordgren IK, Campbell-Harding G, Holloway JW, Holgate ST, Davies DE, Tavassoli A.

Mol Biosyst. 2013 Dec;9(12):3009-14. doi: 10.1039/c3mb70298g.


IFN-gamma, IL-4 and IL-13 modulate responsiveness of human airway smooth muscle cells to IL-13.

Moynihan BJ, Tolloczko B, El Bassam S, Ferraro P, Michoud MC, Martin JG, Laberge S.

Respir Res. 2008 Dec 30;9:84. doi: 10.1186/1465-9921-9-84.


Effect of IL-13 receptor alpha2 levels on the biological activity of IL-13 variant R110Q.

Andrews AL, Bucchieri F, Arima K, Izuhara K, Holgate ST, Davies DE, Holloway JW.

J Allergy Clin Immunol. 2007 Jul;120(1):91-7.


Endogenously expressed IL-13Rα2 attenuates IL-13-mediated responses but does not activate signaling in human lung fibroblasts.

Chandriani S, DePianto DJ, N'Diaye EN, Abbas AR, Jackman J, Bevers J 3rd, Ramirez-Carrozzi V, Pappu R, Kauder SE, Toy K, Ha C, Modrusan Z, Wu LC, Collard HR, Wolters PJ, Egen JG, Arron JR.

J Immunol. 2014 Jul 1;193(1):111-9. doi: 10.4049/jimmunol.1301761.


Reconstitution of a functional human type II IL-4/IL-13 receptor in mouse B cells: demonstration of species specificity.

Andrews R, Rosa L, Daines M, Khurana Hershey G.

J Immunol. 2001 Feb 1;166(3):1716-22.


In vitro and in vivo characterisation of anti-murine IL-13 antibodies recognising distinct functional epitopes.

Berry LM, Adams R, Airey M, Bracher MG, Bourne T, Carrington B, Cross AS, Davies GC, Finney HM, Foulkes R, Gozzard N, Griffin RA, Hailu H, Lamour SD, Lawson AD, Lightwood DJ, McKnight AJ, O'Dowd VL, Oxbrow AK, Popplewell AG, Shaw S, Stephens PE, Sweeney B, Tomlinson KL, Uhe C, Palframan RT.

Int Immunopharmacol. 2009 Feb;9(2):201-6. doi: 10.1016/j.intimp.2008.11.001.


Cytokine regulation of IL-13Ralpha2 and IL-13Ralpha1 in vivo and in vitro.

Zheng T, Zhu Z, Liu W, Lee CG, Chen Q, Homer RJ, Elias JA.

J Allergy Clin Immunol. 2003 Apr;111(4):720-8.


Lysophosphatidic acid induces interleukin-13 (IL-13) receptor alpha2 expression and inhibits IL-13 signaling in primary human bronchial epithelial cells.

Zhao Y, He D, Zhao J, Wang L, Leff AR, Spannhake EW, Georas S, Natarajan V.

J Biol Chem. 2007 Apr 6;282(14):10172-9.


Kinetic analysis of the interleukin-13 receptor complex.

Andrews AL, Holloway JW, Puddicombe SM, Holgate ST, Davies DE.

J Biol Chem. 2002 Nov 29;277(48):46073-8.


IL-13 receptor alpha2 selectively inhibits IL-13-induced responses in the murine lung.

Zheng T, Liu W, Oh SY, Zhu Z, Hu B, Homer RJ, Cohn L, Grusby MJ, Elias JA.

J Immunol. 2008 Jan 1;180(1):522-9.


Allergy-driven alternative splicing of IL-13 receptor alpha2 yields distinct membrane and soluble forms.

Tabata Y, Chen W, Warrier MR, Gibson AM, Daines MO, Hershey GK.

J Immunol. 2006 Dec 1;177(11):7905-12.


A modular interface of IL-4 allows for scalable affinity without affecting specificity for the IL-4 receptor.

Kraich M, Klein M, Patiño E, Harrer H, Nickel J, Sebald W, Mueller TD.

BMC Biol. 2006 Apr 26;4:13.


Equilibrium and kinetic analysis of human interleukin-13 and IL-13 receptor alpha-2 complex formation.

Lacy ER.

J Mol Recognit. 2012 Mar;25(3):184-91. doi: 10.1002/jmr.2150.


Supplemental Content

Support Center